MATTHEW BRYANT: Open Payments
NPI 1154890838 · LEXINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 24 payments from 12 companies in 2025. Trend: 2023 $1,616 · 2024 $1,050 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $93 |
| Novo Nordisk Inc | 5 | $90 |
| ABBVIE INC. | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Amgen Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Dynasplint Systems Inc. | 1 | $26 |
| Grifols USA, LLC | 1 | $25 |
| Lundbeck LLC | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: ELIQUIS, QULIPTA, Wegovy, Ozempic, OTEZLA, REXULTI, Dynasplint, Prolastin-C Liquid.
Industry payments across NC — which companies pay providers there.
